Harvard Bioscience, Inc. (HBIO)
8.23
+0.19
(+2.36%)
USD |
NASDAQ |
Sep 02, 16:00
8.23
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Free Cash Flow : -1.53M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.53M |
| March 31, 2026 | 1.281M |
| December 31, 2025 | 4.866M |
| September 30, 2025 | 6.133M |
| June 30, 2025 | 3.698M |
| March 31, 2025 | -0.332M |
| December 31, 2024 | -1.823M |
| September 30, 2024 | 0.16M |
| June 30, 2024 | 6.073M |
| March 31, 2024 | 10.81M |
| December 31, 2023 | 11.72M |
| September 30, 2023 | 10.92M |
| June 30, 2023 | 7.166M |
| March 31, 2023 | 3.607M |
| December 31, 2022 | -0.438M |
| September 30, 2022 | -3.123M |
| June 30, 2022 | -4.368M |
| March 31, 2022 | -3.276M |
| December 31, 2021 | -0.083M |
| September 30, 2021 | 2.584M |
| June 30, 2021 | 4.655M |
| March 31, 2021 | 6.285M |
| December 31, 2020 | 8.179M |
| September 30, 2020 | 7.55M |
| June 30, 2020 | 9.314M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.601M |
| December 31, 2019 | 6.829M |
| September 30, 2019 | 7.534M |
| June 30, 2019 | 3.046M |
| March 31, 2019 | 3.794M |
| December 31, 2018 | 1.878M |
| September 30, 2018 | -1.776M |
| June 30, 2018 | 1.806M |
| March 31, 2018 | 0.908M |
| December 31, 2017 | 0.128M |
| September 30, 2017 | 2.482M |
| June 30, 2017 | 3.479M |
| March 31, 2017 | 3.993M |
| December 31, 2016 | 3.904M |
| September 30, 2016 | 3.804M |
| June 30, 2016 | 0.18M |
| March 31, 2016 | -1.641M |
| December 31, 2015 | -2.255M |
| September 30, 2015 | -2.875M |
| June 30, 2015 | -2.017M |
| March 31, 2015 | 0.015M |
| December 31, 2014 | 2.346M |
| September 30, 2014 | 2.58M |
| June 30, 2014 | 3.385M |
| March 31, 2014 | 3.006M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agilent Technologies, Inc. | 1.267B |
| Bio-Rad Laboratories, Inc. | 353.10M |
| Bruker Corp. | 93.90M |
| Danaher Corp. | 5.466B |
| Illumina, Inc. | 511.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.323M |
| Cash from Investing (Quarterly) | -0.916M |
| Cash from Financing (Quarterly) | -0.036M |
| Free Cash Flow Per Share (Quarterly) | -0.131 |
| Free Cash Flow to Equity (Quarterly) | -0.677M |
| Free Cash Flow to Firm (Quarterly) | 1.209M |
| Free Cash Flow Yield | -4.15% |